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Human Definitive Hematopoietic Specification 
from Pluripotent Stem Cells Is Regulated by 
Mesodermal Expression of CDX4
 Jolie T. K. Ho
Mentor: Christopher Sturgeon
All adult blood cells arise from hematopoietic stem cells (HSCs), which are multipotent 
stem cells found within the bone marrow. The generation of HSCs from human 
pluripotent stem cells (hPSCs) is a major goal for regenerative medicine, and can lead to 
transplantation of HSCs for the treatment of patients with immunodeficiency or cancers 
such as leukemia or lymphoma. Successful HSC transplantations would address issues 
with donors, and also allow for the correction of genetic illnesses that are untreatable 
with current stem cell technology. The Sturgeon lab aims to produce HSCs from hPSCs 
by replicating in vitro the signals that control embryonic HSC development.
Two programs have been identified as being involved in the development of blood 
cell progenitors: the primitive and the definitive program. The earlier primitive program 
does not yield HSCs, but transiently gives rise to a restricted subset of blood cell lineages. 
Shortly after, the definitive program produces bona fide HSCs, as well as all lineages 
found in the adult. Within our hPSC differentiation system, we have identified WNT 
signaling as a critical determinant of the definitive program, and have further found 
strong CDX gene expression within definitive hematopoietic mesoderm. Specifically, 
exogenous CDX4 expression resulted in repression of primitive hematopoietic potential, 
but increased definitive potential. Meanwhile, knockout CDX4 hPSCs had intact 
primitive potential but a significant decrease in multi-lineage definitive hematopoietic 
potential. Taken together, these findings indicate that CDX4 is a critical transcription 
factor in the regulation of human definitive hematopoietic specification, and provides a 
mechanistic basis for WNT-mediated definitive hematopoietic progenitor specification 
from hPSCs.
